- Report
- September 2023
- 143 Pages
Middle East, Africa
From €1314EUR$1,500USD£1,140GBP
- Report
- September 2023
- 143 Pages
Asia Pacific
From €1314EUR$1,500USD£1,140GBP
- Report
- September 2023
- 128 Pages
North America
From €1314EUR$1,500USD£1,140GBP
- Report
- July 2023
- 298 Pages
Global
From €3153EUR$3,600USD£2,737GBP
- Report
- July 2023
- 141 Pages
Asia Pacific
From €1314EUR$1,500USD£1,140GBP
- Report
- July 2023
- 141 Pages
Europe
From €1314EUR$1,500USD£1,140GBP
- Report
- July 2023
- 128 Pages
North America
From €1314EUR$1,500USD£1,140GBP
- Report
- July 2023
- 141 Pages
Middle East, Africa
From €1314EUR$1,500USD£1,140GBP
- Report
- February 2024
- 145 Pages
Global
From €3722EUR$4,250USD£3,231GBP
- Report
- August 2024
- 144 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- December 2024
- 157 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- August 2024
- 177 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- July 2024
- 161 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- May 2024
- 160 Pages
Global
From €4352EUR$4,969USD£3,777GBP
- Report
- January 2025
- 144 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2023
- 176 Pages
Global
From €3897EUR$4,450USD£3,383GBP
- Report
- February 2023
- 151 Pages
North America
From €3022EUR$3,450USD£2,623GBP
- Report
- December 2022
- 185 Pages
Middle East, Africa, Turkey Middle East, Africa, Turkey
From €3022EUR$3,450USD£2,623GBP
- Report
- November 2023
- 140 Pages
Global
From €3897EUR$4,450USD£3,383GBP
- Report
- August 2022
- 140 Pages
Global
From €3722EUR$4,250USD£3,231GBP

The anticoagulant market within the context of cardiovascular drugs is a rapidly growing sector of the pharmaceutical industry. Anticoagulants are drugs used to prevent the formation of blood clots, which can lead to serious medical conditions such as stroke and heart attack. These drugs are used to reduce the risk of thrombosis, a condition in which a blood clot forms in a blood vessel, blocking the flow of blood. Anticoagulants are also used to treat existing blood clots, as well as to prevent the formation of new ones.
The anticoagulant market is driven by the increasing prevalence of cardiovascular diseases, such as coronary artery disease, stroke, and peripheral artery disease. The rising demand for anticoagulants is also driven by the increasing aging population, as well as the increasing awareness of the importance of preventive healthcare.
Some of the major companies in the anticoagulant market include Bayer AG, Bristol-Myers Squibb, Pfizer, Sanofi, and Johnson & Johnson. These companies are engaged in the development, manufacture, and marketing of anticoagulant drugs. Show Less Read more